Cargando…
Cytokine Induction of VCAM-1 but Not IL13Rα2 on Glioma Cells: A Tale of Two Antibodies
The interleukin-13 receptor alpha2 (IL13Rα2) is a cell surface receptor that is over-expressed by a subset of high-grade gliomas, but not expressed at significant levels by normal brain tissue. For both malignant and non-malignant cells, IL13Rα2 surface expression is reported to be induced by variou...
Autores principales: | Mahadev, Vaidehi, Starr, Renate, Wright, Sarah L., Martinez, Catalina, Jensen, Michael C., Barish, Michael E., Forman, Stephen J., Brown, Christine E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008428/ https://www.ncbi.nlm.nih.gov/pubmed/24787244 http://dx.doi.org/10.1371/journal.pone.0095123 |
Ejemplares similares
-
Glioma IL13Rα2 Is Associated with Mesenchymal Signature Gene Expression and Poor Patient Prognosis
por: Brown, Christine E., et al.
Publicado: (2013) -
Clinical development of IL13Rα2-targeting CAR T cells for the treatment of glioblastoma
por: Brown, Christine E, et al.
Publicado: (2015) -
Adoptive transfer of IL13Rα2-specific T cells for the treatment of glioblastoma: building on clinical achievements with second-generation CARs
por: Brown, Christine E, et al.
Publicado: (2013) -
Spatial organization of heterogeneous immunotherapy target antigen expression in high-grade glioma
por: Barish, Michael E., et al.
Publicado: (2022) -
Expression and pathogenesis of VCAM-1 and VLA-4 cytokines in multiple myeloma
por: Hao, Pan, et al.
Publicado: (2020)